RS
RMTI icon

R Squared’s Rockwell Medical RMTI Stock Holding History

R Squared’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-267
Closed -$5.45K – 1238
2024
Q4 		$5.45K Buy
+267
New +$7.79K 0.01% 1300

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

R Squared's RMTI Position: Q1 2025 in Review

R Squared sold out of Rockwell Medical (RMTI) in Q1 2025, closing a stake of 267 shares — an estimated $5.45K sold.

R Squared first reported a position in RMTI in Q4 2024 and held it in 1 quarter. The position peaked at $5.45K in Q4 2024. 46 funds tracked by Wall St. Rank hold RMTI as of Q1 2025.

  • R Squared reported no remaining Rockwell Medical position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 267 Rockwell Medical shares in Q1 2025, an estimated $5.45K.
  • R Squared first reported a position in Rockwell Medical in Q4 2024 and held it in 1 quarter.
  • R Squared's Rockwell Medical position peaked at $5.45K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.